A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naive Subjects With Type 2 Diabetes (BEGIN ONCE).
Phase of Trial: Phase III
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms BEGIN; BEGIN-ONCE
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 20 Apr 2016 Primary endpoint has been met. (Change from baseline in HbA1c (%)), as per an article published in the Drugs in R and D.
- 20 Apr 2016 Results published in the Drugs in R and D